Company: STAA
Filing Date: 2025-10-30
Form Type: DEFA14A
Source: 0001193125-25-258558
Chunk: 29

Company: STAAR SURGICAL CO
Filing Date: 2025-10-30
Form: DEFA14A
Chunk 29
---
 |     | $                 | 4.6 |     |         | 4.4x |
| 12/18/2020        |     | Koninklijke Philips N.V.      |     | BioTelemetry, Inc.           |     | $                 | 2.7 |     |         | 6.2x |
| 11/04/2019        |     | Stryker Corporation           |     | Wright Medical Group N.V.    |     | $                 | 5.4 |     |         | 5.9x |
| 08/30/2018        |     | Stryker Corporation           |     | K2M Group Holdings, Inc.     |     | $                 | 1.4 |     |         | 5.1x |

Based on its professional judgment and experience and taking into consideration the observed multiples for the selected transactions, Citi then applied an illustrative EV / LTM Revenue multiple reference range of 3.1x to 6.3x to the LTM revenue of STAAR as of June 27, 2025, to derive ranges of implied enterprise value for STAAR. To the range of implied enterprise values it derived for STAAR, Citi added STAAR’s net cash of $185 million as of June 27, 2025 and divided the results by the diluted common stock share count of STAAR calculated using the treasury stock method, based on equity information as of July 30, 2025 as provided by STAAR management. This analysis indicated an approximate implied per share equity value reference range for STAAR of $17.15 to $30.80, as compared to the closing share price of the STAAR common stock as of August 1, 2025, of $17.76, and the Merger Consideration of $28.00. 17

The section titled “—Discounted Cash Flow Analysis” on page 57 of the proxy statement is hereby amended and supplemented as follows:

Citi conducted a discounted cash flow analysis of STAAR using
the Projections for the purpose of determining an implied fully diluted equity value per share for STAAR’s common stock. Based on the Projections, Citi calculated the estimated present value of unlevered free cash flows that STAAR was
forecasted to generate during the fiscal years ending December 31, 2025 through December 31, 2030. Citi calculated a range of illustrative terminal